Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
Clinical trial NCT06001684 · COMPLETED
Trial details
- NCT number
- NCT06001684
- Sponsor
- Imbioray (Hangzhou) Biomedicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-12-26
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.